2023 Q1 Form 10-Q Financial Statement

#000106299323005132 Filed on February 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $12.50M $15.87M $15.11M
YoY Change -22.44% 5.06% 57.13%
Cost Of Revenue $11.84M $11.95M $10.13M
YoY Change -25.32% 17.97% 61.69%
Gross Profit $664.9K $3.927M $4.982M
YoY Change 146.44% -21.18% 48.62%
Gross Profit Margin 5.32% 24.74% 32.97%
Selling, General & Admin $7.771M $7.489M $15.91M
YoY Change -28.16% -52.92% 109.96%
% of Gross Profit 1168.83% 190.7% 319.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $290.0K $203.8K $159.0K
YoY Change -10.6% 28.15% -43.6%
% of Gross Profit 43.61% 5.19% 3.19%
Operating Expenses $7.771M $7.489M $15.91M
YoY Change -28.16% -52.92% 109.96%
Operating Profit -$7.106M -$3.562M -$10.92M
YoY Change -32.63% -67.39% 158.65%
Interest Expense -$421.8K $424.6K $142.9K
YoY Change -15.04% 197.11% 4.37%
% of Operating Profit
Other Income/Expense, Net -$424.6K $187.7K
YoY Change -326.25% -237.06%
Pretax Income -$7.528M -$3.986M -$10.74M
YoY Change -31.84% -62.87% 146.24%
Income Tax
% Of Pretax Income
Net Earnings -$7.528M -$3.986M -$10.74M
YoY Change -31.84% -62.87% 146.22%
Net Earnings / Revenue -60.23% -25.11% -71.05%
Basic Earnings Per Share -$0.03 -$0.10
Diluted Earnings Per Share -$0.76 -$0.03 -$101.7K
COMMON SHARES
Basic Shares Outstanding 148.0M shares 145.8M shares 105.6M shares
Diluted Shares Outstanding 145.8M shares 105.6M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.039M $2.193M $3.293M
YoY Change -32.15% -33.41% 91.47%
Cash & Equivalents $1.039M $2.193M $3.293M
Short-Term Investments
Other Short-Term Assets $2.801M $2.521M $2.430M
YoY Change -10.09% 3.74% 56.77%
Inventory $5.591M $8.738M $8.830M
Prepaid Expenses
Receivables $6.520M $8.774M $7.773M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.95M $22.23M $22.33M
YoY Change -24.6% -0.45% 81.96%
LONG-TERM ASSETS
Property, Plant & Equipment $2.058M $1.859M $1.170M
YoY Change 71.4% 58.83% -1.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.078M $1.858M $1.170M
YoY Change 54.74% 58.82% -2.49%
TOTAL ASSETS
Total Short-Term Assets $15.95M $22.23M $22.33M
Total Long-Term Assets $2.078M $1.858M $1.170M
Total Assets $18.03M $24.08M $23.50M
YoY Change -19.87% 2.5% 74.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.62M $14.11M $7.389M
YoY Change 11.25% 90.95% 47.78%
Accrued Expenses $1.996M $2.225M $1.572M
YoY Change -1.98% 41.58% -21.02%
Deferred Revenue
YoY Change
Short-Term Debt $9.596M $6.391M $6.427M
YoY Change 3.54% -0.55% 60.67%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $23.34M $22.90M $15.39M
YoY Change 6.5% 48.84% 37.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $22.22K $32.84K $175.0K
YoY Change -87.57% -81.24% -46.96%
Total Long-Term Liabilities $22.22K $32.84K $175.0K
YoY Change -87.57% -81.24% -58.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.34M $22.90M $15.39M
Total Long-Term Liabilities $22.22K $32.84K $175.0K
Total Liabilities $23.37M $22.94M $15.56M
YoY Change 5.73% 47.37% 33.58%
SHAREHOLDERS EQUITY
Retained Earnings -$137.1M -$129.4M
YoY Change 25.17%
Common Stock $10.01K $147.9K
YoY Change -90.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.337M $1.149M $7.934M
YoY Change
Total Liabilities & Shareholders Equity $18.03M $24.08M $23.50M
YoY Change -19.87% 2.5% 74.43%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$7.528M -$3.986M -$10.74M
YoY Change -31.84% -62.87% 146.22%
Depreciation, Depletion And Amortization $290.0K $203.8K $159.0K
YoY Change -10.6% 28.15% -43.6%
Cash From Operating Activities -$509.4K -$469.5K -$7.210M
YoY Change -91.34% -93.49% 383.88%
INVESTING ACTIVITIES
Capital Expenditures $656.8K -$445.4K -$177.9K
YoY Change -231.71% 150.35% 196.53%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$656.8K $445.4K -$177.9K
YoY Change 31.71% -350.35% 196.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.13K -40.62K 262.0K
YoY Change -99.74% -115.5% -136.9%
NET CHANGE
Cash From Operating Activities -509.4K -469.5K -7.210M
Cash From Investing Activities -656.8K 445.4K -177.9K
Cash From Financing Activities 12.13K -40.62K 262.0K
Net Change In Cash -1.154M -64.64K -7.126M
YoY Change -34.51% -99.09% 215.3%
FREE CASH FLOW
Cash From Operating Activities -$509.4K -$469.5K -$7.210M
Capital Expenditures $656.8K -$445.4K -$177.9K
Free Cash Flow -$1.166M -$24.02K -$7.032M
YoY Change -78.33% -99.66% 391.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 wter Employee Service Share Based Compensation Compensation Cost Not Yet Recognized Year Two
EmployeeServiceShareBasedCompensationCompensationCostNotYetRecognizedYearTwo
3227030 usd
CY2022Q4 wter Employee Service Share Based Compensation Compensation Cost Not Yet Recognized Year Three
EmployeeServiceShareBasedCompensationCompensationCostNotYetRecognizedYearThree
185586 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7425656 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 usd
CY2022Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
62388 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
7488961 usd
CY2022Q4 wter Debt Conversion Expense
DebtConversionExpense
0 usd
CY2021Q4 wter Debt Conversion Expense
DebtConversionExpense
0 usd
wter Debt Conversion Expense
DebtConversionExpense
2405612 usd
wter Debt Conversion Expense
DebtConversionExpense
0 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145825459 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105580951 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133957675 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133957675 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95891561 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95891561 shares
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
2227031 usd
CY2021Q2 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
652777 usd
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
651648 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4995250 usd
CY2021Q3 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
11904220 usd
CY2021Q3 wter Common Shares Issued To Nonemployees And Employees
CommonSharesIssuedToNonemployeesAndEmployees
307719 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
625556 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
59950 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10378473 usd
CY2021Q4 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
833316 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10736033 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2227030 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5268592 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
222017 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7493408 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
625369 usd
CY2022Q3 wter Common Shares Issued In Connection With Conversion Of Note Payable
CommonSharesIssuedInConnectionWithConversionOfNotePayable
4976473 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
386072 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
108180 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1531062 usd
us-gaap Selling Expense
SellingExpense
10555978 usd
us-gaap Selling Expense
SellingExpense
11824231 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
51277376 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39684465 usd
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
The principal amount of the Revolving Facility outstanding bears interest at a rate per annum equal to (i) a fluctuating interest rate per annum equal at all times to the rate of interest announced, from time to time, within Wells Fargo Bank at its principal office in San Francisco as its "prime rate," plus (ii) 3.25%, payable monthly in arrears. The interest rate as of December 31, 2022 and March 31, 2022 was 9.5% and 8.0%, respectively.
wter Line Of Credit Facility Termination Fee
LineOfCreditFacilityTerminationFee
0.01 pure
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q2 wter Aggregate Cash Payments
AggregateCashPayments
3000000 usd
CY2022Q4 wter Additional Aggregate Cash Payments
AdditionalAggregateCashPayments
1750000 usd
CY2022Q4 wter Aggregate Cash Payments For Fiscal Year Three
AggregateCashPaymentsForFiscalYearThree
250000 usd
CY2022Q4 wter Aggregate Cash Payments For Fiscal Year Two
AggregateCashPaymentsForFiscalYearTwo
250000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
806758 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2420273 usd
wter Employee Service Share Based Compensation Compensation Cost Not Yet Recognized Quarter Four
EmployeeServiceShareBasedCompensationCompensationCostNotYetRecognizedQuarterFour
806758 usd
wter Employee Service Share Based Compensation Compensation Cost Not Yet Recognized Quarter Three
EmployeeServiceShareBasedCompensationCompensationCostNotYetRecognizedQuarterThree
806758 usd
CY2021Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
92481 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
285007 usd
CY2022Q4 wter Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
159384 usd
CY2022Q4 wter Operating Lease Right Of Use Asset Non Current
OperatingLeaseRightOfUseAssetNonCurrent
29862 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
54018 usd
dei Trading Symbol
TradingSymbol
WTER
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
148009280 shares
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2192867 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1531062 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8774283 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
0 usd
wter Debt Conversion Expense
DebtConversionExpense
2405612 usd
wter Debt Conversion Expense
DebtConversionExpense
0 usd
dei Entity Registrant Name
EntityRegistrantName
THE ALKALINE WATER COMPANY INC.
dei Entity Address Address Line1
EntityAddressAddressLine1
8541 E. Anderson Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
dei City Area Code
CityAreaCode
480
dei Local Phone Number
LocalPhoneNumber
656-2423
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001532390
dei Security12b Title
Security12bTitle
Common stock
CY2021Q4 wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
330551 usd
wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
0 usd
wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
330551 usd
CY2021Q2 wter Common Shares Issued To Nonemployees And Employees
CommonSharesIssuedToNonemployeesAndEmployees
40000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
48231 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
14722239 usd
CY2021Q4 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2021Q4 wter Common Shares Issued To Non Employees
CommonSharesIssuedToNonEmployees
20700 usd
CY2021Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
3093350 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7933572 usd
CY2022Q3 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
5653544 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8397208 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3244250 usd
CY2022Q4 wter Stock Issued During Period Value Connection With Issuance Of Preferred Stock Series E
StockIssuedDuringPeriodValueConnectionWithIssuanceOfPreferredStockSeriesE
1100000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1100000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2192867 usd
us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<div style="font-size:10pt"> <div style="font-family:Times New Roman,Times,serif"> <div style="text-decoration:underline;margin-bottom:11pt">Property and Equipment</div> </div> </div> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company records all property and equipment at cost less accumulated depreciation. Improvements are capitalized while repairs and maintenance costs are expensed as incurred. Depreciation is calculated using the straight-line (half-life convention) method over the estimated useful life of the assets, which the Company has determined to be 3 years.</span></span></p>
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
3 years
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-size:10pt"> <div style="font-family:Times New Roman,Times,serif"> <div style="text-decoration:underline;margin-top:10pt;margin-bottom:11pt">Concentration Risks</div> </div> </div> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have 2 major customers that together account for 23% (13% and 10%, respectively) of accounts receivable at December 31, 2022, 3 customer that accounts for 42% (17%, 15%, and 10% respectively) of total revenues for the three months ended December 31, 2022 and 2 customers that accounts for 30% (17% and 13%, respectively) of the total revenues earned for the nine months ended December 31, 2022. The Company has 1 vendors that accounts for 17% of purchases for the three months ended December 31, 2022 and 2 vendors that accounted for 38% (27%,and 11% respectively) of purchases for the nine months ended December 31, 2022.</span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company had 2 major customers that together accounted for 32% (17% and 15%, respectively) of accounts receivable at December 31, 2021, 2 customer that accounted for 34% (17% and 17%, respectively) of total revenues for the three months ended December 31, 2021 and 2 customers that accounted for 33% (19% and 14%, respectively) of the total revenues earned for the nine months ended December 31, 2021. The Company had 3 vendors that accounted for 52% (27%, 14% and 11% respectively) of purchases for the three months ended December 31, 2021 and 3 vendors that accounted for 49% (25%, 14% and 10% respectively) of purchases for the nine months ended December 31, 2021.</span></span></p>
us-gaap Revenues
Revenues
39684465 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
2971904 usd
us-gaap Gross Profit
GrossProfit
10153895 usd
us-gaap Depreciation
Depreciation
610162 usd
us-gaap Depreciation
Depreciation
477045 usd
us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
Under the terms of the Credit Agreement, SCM has agreed to make cash advances to our company in an aggregate principal at any one time outstanding not to exceed the lesser of (i) $10 million (the "Revolving Loan Commitment Amount") and (ii) the Borrowing Base (defined to mean, as of any date of determination, 85% of net eligible billed receivables plus 65% of eligible unbilled receivables, minus certain reserves).
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6391316 usd
us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.00083 pure
us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0035 pure
wter Line Of Credit Facility Interest Increase Upon Default
LineOfCreditFacilityInterestIncreaseUponDefault
0.05 pure
wter Employee Service Share Based Compensation Compensation Cost Not Yet Recognized Quarter Three
EmployeeServiceShareBasedCompensationCompensationCostNotYetRecognizedQuarterThree
806758 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3227030 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5500 usd
CY2022Q4 us-gaap Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
193847 usd
CY2022Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1051428 usd
CY2022Q3 wter Warrants Exercised During Period Original Exercise Price
WarrantsExercisedDuringPeriodOriginalExercisePrice
1.25
CY2022Q3 wter Warrants Exercised During Period Original Exercise Price
WarrantsExercisedDuringPeriodOriginalExercisePrice
1.25
CY2022Q3 wter Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
0.46
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.25
CY2022Q4 wter Implied Price Of Stock Options Granted
ImpliedPriceOfStockOptionsGranted
0.22
CY2022Q4 wter Value Of Stock Options Granted
ValueOfStockOptionsGranted
194400 usd
CY2022Q4 wter Stock Option Expense
StockOptionExpense
8100 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
948000 shares
CY2022Q4 wter Reversal Of Prior Stock Option Expense
ReversalOfPriorStockOptionExpense
394044 usd
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2285714 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.46
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1051428 usd
CY2022Q3 wter Warrants Original Exercise Price Per Share
WarrantsOriginalExercisePricePerShare
1.25
CY2022Q3 wter Warrants Original Exercise Price Per Share
WarrantsOriginalExercisePricePerShare
1.25
CY2022Q3 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.46

Files In Submission

Name View Source Status
0001062993-23-005132-index-headers.html Edgar Link pending
0001062993-23-005132-index.html Edgar Link pending
0001062993-23-005132.txt Edgar Link pending
0001062993-23-005132-xbrl.zip Edgar Link pending
exhibit10-66.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wter-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
wter-20221231_cal.xml Edgar Link unprocessable
wter-20221231_def.xml Edgar Link unprocessable
wter-20221231_pre.xml Edgar Link unprocessable
wter-20221231_lab.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed